{"resourceType":"ArtifactAssessment","id":"example-certainty-rating","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative: ArtifactAssessment</b><a name=\"example-certainty-rating\"> </a></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource ArtifactAssessment &quot;example-certainty-rating&quot; </p></div><p><b>identifier</b>: FEvIR Object Identifier:Â 27756</p><p><b>date</b>: 2021-11-02T14:48:59.89Z</p><p><b>copyright</b>: https://creativecommons.org/licenses/by-nc-sa/4.0/</p><p><b>artifact</b>: <a href=\"broken-link.html\">Evidence/18812: Critically appraised summary of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19</a></p><blockquote><p><b>content</b></p><p><b>informationType</b>: rating</p><p><b>summary</b>: serious concerns with risk of bias, inconsistency, and imprecision</p><p><b>type</b>: Overall certainty <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#Overall)</span></p><p><b>classifier</b>: Very low quality <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#very-low)</span></p><p><b>author</b>: <span>: Brian S. Alper</span></p><p><b>freeToShare</b>: true</p><h3>Components</h3><table class=\"grid\"><tr><td>-</td><td><b>InformationType</b></td><td><b>Summary</b></td><td><b>Type</b></td><td><b>Classifier</b></td><td><b>Author</b></td></tr><tr><td>*</td><td>rating</td><td>risk of bias in both included trials</td><td>Risk of bias <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#RiskOfBias)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td>high degree of heterogeneity (I-squared 80.7%) with confidence intervals of 2 trial effect estimates barely overlapping</td><td>Inconsistency <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#Inconsistency)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td> </td><td>Indirectness <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#Indirectness)</span></td><td>no serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#no-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td>95% confidence interval includes both large effects and no effects</td><td>Imprecision <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#Imprecision)</span></td><td>serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#serious-concern)</span></td><td><span>: Brian S. Alper</span></td></tr><tr><td>*</td><td>rating</td><td> </td><td>Publication bias <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-type.html\">Evidence Certainty Type</a>#PublicationBias)</span></td><td>no serious concern <span style=\"background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki\"> (<a href=\"codesystem-certainty-rating.html\">Evidence Certainty Rating</a>#no-concern)</span></td><td><span>: Brian S. Alper</span></td></tr></table></blockquote></div>"},"identifier":[{"type":{"text":"FEvIR Object Identifier"},"system":"https://fevir.net","value":"27756","assigner":{"display":"Computable Publishing LLC"}}],"date":"2021-11-02T14:48:59.890Z","copyright":"https://creativecommons.org/licenses/by-nc-sa/4.0/","artifactReference":{"reference":"Evidence/18812","type":"Evidence","display":"Critically appraised summary of all-cause mortality in meta-analysis of RCTs of heparin for moderately ill patients with COVID-19"},"content":[{"informationType":"rating","summary":"serious concerns with risk of bias, inconsistency, and imprecision","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"Overall","display":"Overall certainty"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"very-low","display":"Very low quality"}]}],"author":{"display":"Brian S. Alper"},"freeToShare":true,"component":[{"informationType":"rating","summary":"risk of bias in both included trials","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"RiskOfBias","display":"Risk of bias"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"serious-concern","display":"serious concern"}]}],"author":{"display":"Brian S. Alper"}},{"informationType":"rating","summary":"high degree of heterogeneity (I-squared 80.7%) with confidence intervals of 2 trial effect estimates barely overlapping","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"Inconsistency","display":"Inconsistency"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"serious-concern","display":"serious concern"}]}],"author":{"display":"Brian S. Alper"}},{"informationType":"rating","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"Indirectness","display":"Indirectness"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"no-concern","display":"no serious concern"}]}],"author":{"display":"Brian S. Alper"}},{"informationType":"rating","summary":"95% confidence interval includes both large effects and no effects","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"Imprecision","display":"Imprecision"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"serious-concern","display":"serious concern"}]}],"author":{"display":"Brian S. Alper"}},{"informationType":"rating","type":{"coding":[{"system":"http://hl7.org/fhir/certainty-type","code":"PublicationBias","display":"Publication bias"}]},"classifier":[{"coding":[{"system":"http://hl7.org/fhir/certainty-rating","code":"no-concern","display":"no serious concern"}]}],"author":{"display":"Brian S. Alper"}}]}]}